<VariationArchive VariationID="322029" VariationName="NM_012452.3(TNFRSF13B):c.204dup (p.Leu69fs)" VariationType="Duplication" Accession="VCV000322029" Version="50" RecordType="classified" NumberOfSubmissions="14" NumberOfSubmitters="13" DateLastUpdated="2024-07-15" DateCreated="2016-12-06" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="327424" VariationID="322029">
      <GeneList>
        <Gene Symbol="TNFRSF13B" FullName="TNF receptor superfamily member 13B" GeneID="23495" HGNC_ID="HGNC:18153" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17p11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="16939081" stop="16972118" display_start="16939081" display_stop="16972118" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="16842397" stop="16875401" display_start="16842397" display_stop="16875401" Strand="-" />
          </Location>
          <OMIM>604907</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_012452.3(TNFRSF13B):c.204dup (p.Leu69fs)</Name>
      <CanonicalSPDI>NC_000017.11:16948978:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>17p11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="16948978" stop="16948979" display_start="16948978" display_stop="16948979" variantLength="1" positionVCF="16948978" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="16852292" stop="16852293" display_start="16852292" display_stop="16852293" variantLength="1" positionVCF="16852292" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
      </Location>
      <ProteinChange>L69fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.16852293dup" Assembly="GRCh37">
            <Expression>NC_000017.10:g.16852293dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.16948979dup" Assembly="GRCh38">
            <Expression>NC_000017.11:g.16948979dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007281.1" sequenceAccession="NG_007281" sequenceVersion="1" change="g.28110dup">
            <Expression>NG_007281.1:g.28110dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_012452.3" sequenceAccession="NM_012452" sequenceVersion="3" change="c.204dup" MANESelect="true">
            <Expression>NM_012452.3:c.204dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_036584.1" sequenceAccession="NP_036584" sequenceVersion="1" change="p.Leu69fs">
            <Expression>NP_036584.1:p.Leu69fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_120" sequenceAccession="LRG_120">
            <Expression>LRG_120:g.28110dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_012452.2" sequenceAccession="NM_012452" sequenceVersion="2" change="c.204dupA">
            <Expression>NM_012452.2:c.204dupA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_012452.3" sequenceAccession="NM_012452" sequenceVersion="3" change="c.204dupA" MANESelect="true">
            <Expression>NM_012452.3:c.204dupA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA8414070" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="604907.0004" DB="OMIM" />
        <XRef Type="rs" ID="72553875" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00030" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00031" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00039" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00041" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00080" Source="NHLBI Exome Sequencing Project (ESP) Exome Variant Server" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_012452.3(TNFRSF13B):c.204dup (p.Leu69fs) AND Common Variable Immune Deficiency, Dominant" Accession="RCV000380683" Version="6">
        <ClassifiedConditionList TraitSetID="33581">
          <ClassifiedCondition DB="MedGen" ID="CN239265">Common Variable Immune Deficiency, Dominant</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-06-14" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_012452.3(TNFRSF13B):c.204dup (p.Leu69fs) AND not provided" Accession="RCV000520212" Version="30">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-10-06" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_012452.3(TNFRSF13B):c.204dup (p.Leu69fs) AND Immunodeficiency, common variable, 2" Accession="RCV000557905" Version="14">
        <ClassifiedConditionList TraitSetID="1477">
          <ClassifiedCondition DB="MedGen" ID="C3150354">Immunodeficiency, common variable, 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-12-25" SubmissionCount="5">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_012452.3(TNFRSF13B):c.204dup (p.Leu69fs) AND Immunodeficiency, common variable, 1" Accession="RCV002283475" Version="2">
        <ClassifiedConditionList TraitSetID="1539">
          <ClassifiedCondition DB="MedGen" ID="C3149378">Immunodeficiency, common variable, 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2022-05-01" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_012452.3(TNFRSF13B):c.204dup (p.Leu69fs) AND Immunoglobulin A deficiency 2" Accession="RCV002460349" Version="2">
        <ClassifiedConditionList TraitSetID="1478">
          <ClassifiedCondition DB="MedGen" ID="C1836032">Immunoglobulin A deficiency 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2005-08-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_012452.3(TNFRSF13B):c.204dup (p.Leu69fs) AND multiple conditions" Accession="RCV003224262" Version="2">
        <ClassifiedConditionList TraitSetID="12971">
          <ClassifiedCondition DB="MedGen" ID="C3150354">Immunodeficiency, common variable, 2</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1836032">Immunoglobulin A deficiency 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-12-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_012452.3(TNFRSF13B):c.204dup (p.Leu69fs) AND TNFRSF13B-related disorder" Accession="RCV003422282" Version="4">
        <ClassifiedConditionList TraitSetID="89602">
          <ClassifiedCondition>TNFRSF13B-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-03-06" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_012452.3(TNFRSF13B):c.204dup (p.Leu69fs) AND Hyper-IgM syndrome type 2" Accession="RCV003995848" Version="1">
        <ClassifiedConditionList TraitSetID="1418">
          <ClassifiedCondition DB="MedGen" ID="C1720956">Hyper-IgM syndrome type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-25" NumberOfSubmissions="14" NumberOfSubmitters="13" DateCreated="2016-12-06" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(8); Likely pathogenic(2); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">16007086</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16007087</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17392798</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18981294</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21547394</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22884984</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23956760</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26046366</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26100089</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27123465</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(8); Likely pathogenic(2); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2022-11-28">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-11-28">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2017-12-19">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="89602" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="72017" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">TNFRSF13B-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">TNFRSF13B-related condition</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="33581" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36462" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Common Variable Immune Deficiency, Dominant</ElementValue>
                <XRef ID="143907" DB="Illumina Laboratory Services, Illumina" />
              </Name>
              <XRef ID="CN239265" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1539" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="5328" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Immunodeficiency, common variable, 1</ElementValue>
                <XRef ID="MONDO:0011864" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ANTIBODY DEFICIENCY DUE TO ICOS DEFECT</ElementValue>
                <XRef Type="MIM" ID="607594" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CVID1</ElementValue>
                <XRef Type="MIM" ID="607594" DB="OMIM" />
              </Symbol>
              <XRef ID="1572" DB="Orphanet" />
              <XRef ID="C3149378" DB="MedGen" />
              <XRef ID="MONDO:0011864" DB="MONDO" />
              <XRef Type="MIM" ID="607594" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1477" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5329" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Immunodeficiency, common variable, 2</ElementValue>
                <XRef ID="MONDO:0009413" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hypogamma-globulinemia, acquired</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Immunoglobulin deficiency, late-onset</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ANTIBODY DEFICIENCY DUE TO TACI DEFECT</ElementValue>
                <XRef Type="MIM" ID="240500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPOGAMMAGLOBULINEMIA DUE TO TACI DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="240500" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CVID2</ElementValue>
                <XRef Type="MIM" ID="240500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15184" />
                <XRef ID="15184" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="1572" DB="Orphanet" />
              <XRef ID="C3150354" DB="MedGen" />
              <XRef ID="MONDO:0009413" DB="MONDO" />
              <XRef Type="MIM" ID="240500" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1478" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="5332" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Immunoglobulin A, selective deficiency of, TACI related</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">IgA, selective deficiency of, TACI related</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Immunoglobulin A deficiency 2</ElementValue>
                <XRef ID="Immunoglobulin+A+deficiency+2/3784" DB="Genetic Alliance" />
                <XRef ID="MONDO:0012291" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">IGAD2</ElementValue>
                <XRef Type="MIM" ID="609529" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10198" />
                <XRef ID="10198" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C1836032" DB="MedGen" />
              <XRef ID="MONDO:0012291" DB="MONDO" />
              <XRef Type="MIM" ID="609529" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1418" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5327" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hyper-IgM Immunodeficiency Syndrome, Type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hyper-IgM syndrome type 2</ElementValue>
                <XRef ID="MONDO:0011528" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Immunodeficiency with hyper IgM type 2</ElementValue>
                <XRef ID="Immunodeficiency+with+hyper+IgM+type+2/3777" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AID</ElementValue>
                <XRef ID="GTR000266553" DB="Genetic Testing Registry (GTR)" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HIGM2</ElementValue>
                <XRef Type="MIM" ID="605258" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10578" />
                <XRef ID="10578" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="101089" DB="Orphanet" />
              <XRef ID="C1720956" DB="MedGen" />
              <XRef ID="MONDO:0011528" DB="MONDO" />
              <XRef Type="MIM" ID="605258" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="12971" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5329" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Immunodeficiency, common variable, 2</ElementValue>
                <XRef ID="MONDO:0009413" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hypogamma-globulinemia, acquired</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Immunoglobulin deficiency, late-onset</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ANTIBODY DEFICIENCY DUE TO TACI DEFECT</ElementValue>
                <XRef Type="MIM" ID="240500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPOGAMMAGLOBULINEMIA DUE TO TACI DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="240500" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CVID2</ElementValue>
                <XRef Type="MIM" ID="240500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15184" />
                <XRef ID="15184" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="1572" DB="Orphanet" />
              <XRef ID="C3150354" DB="MedGen" />
              <XRef ID="MONDO:0009413" DB="MONDO" />
              <XRef Type="MIM" ID="240500" DB="OMIM" />
            </Trait>
            <Trait ID="5332" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Immunoglobulin A, selective deficiency of, TACI related</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">IgA, selective deficiency of, TACI related</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Immunoglobulin A deficiency 2</ElementValue>
                <XRef ID="Immunoglobulin+A+deficiency+2/3784" DB="Genetic Alliance" />
                <XRef ID="MONDO:0012291" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">IGAD2</ElementValue>
                <XRef Type="MIM" ID="609529" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10198" />
                <XRef ID="10198" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C1836032" DB="MedGen" />
              <XRef ID="MONDO:0012291" DB="MONDO" />
              <XRef Type="MIM" ID="609529" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="25810" SubmissionDate="2011-11-17" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="604907.0004_IMMUNODEFICIENCY, COMMON VARIABLE, 2" title="TNFRSF13B, 1-BP INS, 204A_IMMUNODEFICIENCY, COMMON VARIABLE, 2" />
        <ClinVarAccession Accession="SCV000025810" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2005-08-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a woman with CVID2 (240500), Castigli et al. (2005) identified compound heterozygosity for 2 mutations in the TNFRSF13B gene: a 1-bp insertion (204insA) at the beginning of exon 3 and C104R (604907.0001). The insertion resulted in a frameshift after amino acid 68 and premature termination of the protein 11 amino acids downstream. The patient's mother, who was heterozygous for 204insA, had selective IgA deficiency-2 (609529), whereas the patient's 2 children, who were also heterozygous for 204insA, had CVID2.</Attribute>
              <Citation>
                <ID Source="PubMed">16007086</ID>
              </Citation>
              <XRef DB="OMIM" ID="240500" Type="MIM" />
              <XRef DB="OMIM" ID="609529" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TNFRSF13B" />
          </GeneList>
          <Name>TNFRSF13B, 1-BP INS, 204A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 204A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="604907.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">IMMUNODEFICIENCY, COMMON VARIABLE, 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="25811" SubmissionDate="2011-11-17" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="604907.0004_IMMUNOGLOBULIN A DEFICIENCY 2" title="TNFRSF13B, 1-BP INS, 204A_IMMUNOGLOBULIN A DEFICIENCY 2" />
        <ClinVarAccession Accession="SCV000025811" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2005-08-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a woman with CVID2 (240500), Castigli et al. (2005) identified compound heterozygosity for 2 mutations in the TNFRSF13B gene: a 1-bp insertion (204insA) at the beginning of exon 3 and C104R (604907.0001). The insertion resulted in a frameshift after amino acid 68 and premature termination of the protein 11 amino acids downstream. The patient's mother, who was heterozygous for 204insA, had selective IgA deficiency-2 (609529), whereas the patient's 2 children, who were also heterozygous for 204insA, had CVID2.</Attribute>
              <Citation>
                <ID Source="PubMed">16007086</ID>
              </Citation>
              <XRef DB="OMIM" ID="240500" Type="MIM" />
              <XRef DB="OMIM" ID="609529" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TNFRSF13B" />
          </GeneList>
          <Name>TNFRSF13B, 1-BP INS, 204A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 204A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="604907.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">IMMUNOGLOBULIN A DEFICIENCY 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="714442" SubmissionDate="2016-10-18" DateLastUpdated="2016-12-06" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="674464|Common Variable Immune Deficiency, Dominant" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000400921" DateUpdated="2016-12-06" DateCreated="2016-12-06" Type="SCV" Version="2" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-06-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16007086</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21547394</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23956760</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18981294</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22884984</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27123465</ID>
          </Citation>
          <Comment>The c.204dupA (p.Leu69ThrfsTer12) variant is a frameshift variant and is predicted to result in a premature termination of the protein. The p.Leu69ThrfsTer12 variant has been reported in at least five studies in individuals with either CVID or IgA deficiency (Castigli et al. 2005; Salzer et al. 2009; Speletas et al. 2011; Freiberger et al. 2012; Pulvirenti et al. 2016) and found in a compound heterozygous state with a missense variant in three patients with CVID and in a heterozygous state in six individuals with IgA deficiency. One multigenerational family study showed this variant segregating with disease in individuals with IgA deficiency or CVID, suggesting clinical heterogeneity with a potential spectrum of disease (Castigli et al. 2005). The p.Leu69ThrfsTer12 variant was absent from at least 1250 controls, but is reported at a frequency of 0.00109 in the European American population of the Exome Sequencing Project. Functional studies show that the p.Leu69ThrfsTer12 variant results in a severely impaired secretion of IgG and IgA in B cells in response to the TACI ligand, APRIL (Castigli et al. 2005). Castigli et al. (2005) also showed there was no detectable protein product on the surface of 293 cells carrying the p.Leu69ThrfsTer12 variant. However, Salzer et al. (2009) showed a single EBV-transformed cell line carrying a heterozygous p.Leu69ThrfsTer12 variant displayed no significant differences in TACI expression or ligand binding capacity compared with controls. Based on the potential impact of frameshift variants and the supporting evidence, the p.Leu69ThrfsTer12 variant is classified as a variant of unknown significance but suspicious for pathogenicity for common variable immune deficiency.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification 20161018</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/r4jv4v98/icsl_variant_classification_20161018.pdf</URL>
            <CitationText>ICSL_Variant_Classification_20161018.pdf</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TNFRSF13B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_012452.2:c.204dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Common Variable Immune Deficiency, Dominant</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>ICSL_2016Q4</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1204226" SubmissionDate="2023-11-22" DateLastUpdated="2023-11-25" DateCreated="2017-12-19">
        <ClinVarSubmissionID localKey="GDXSV:314413" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000617814" DateUpdated="2023-11-25" DateCreated="2017-12-19" Type="SCV" Version="5" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Reported in association with both autosomal dominant and autosomal recessive forms of CVID and immunoglobulin A deficiency; however, most commonly associated with autosomal recessive inheritance (Castigli et al., 2005; Salzer et al., 2009; Speletas et al., 2011; Pulvirenti et al., 2016); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 26100089, 27266541, 26046366, 23956760, 18981294, 22884984, 27123465, 21547394, 30090215, 16007086)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TNFRSF13B" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:754288</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_012452.2:c.204dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_149_20221207054205</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_236_20231122054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_50_20210924044205</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_77_20211222054205</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1242393" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2017-12-26">
        <ClinVarSubmissionID localKey="2065692|MedGen:C3150354" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000649854" DateUpdated="2024-02-20" DateCreated="2017-12-26" Type="SCV" Version="8" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16007087</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27123465</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16007086</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17392798</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18981294</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22884984</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26046366</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26100089</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27123465</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Leu69Thrfs*12) in the TNFRSF13B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TNFRSF13B are known to be pathogenic (PMID: 16007087, 27123465). This variant is present in population databases (rs72553875, gnomAD 0.6%). This premature translational stop signal has been observed in individuals with common variable immunodeficiency or IgA deficiency (PMID: 16007086, 17392798, 18981294, 22884984, 26046366, 26100089, 27123465). ClinVar contains an entry for this variant (Variation ID: 322029). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TNFRSF13B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.16852292_16852293insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3150354" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2246111" SubmissionDate="2019-10-22" DateLastUpdated="2020-01-09" DateCreated="2020-01-09">
        <ClinVarSubmissionID localKey="NC_000017.10:g.16852292_16852293insT|OMIM:240500" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001140308" DateUpdated="2020-01-09" DateCreated="2020-01-09" Type="SCV" Version="1" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-05-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2017</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TNFRSF13B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.16852292_16852293insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="240500" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_020</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5031043" SubmissionDate="2022-09-02" DateLastUpdated="2022-09-17" DateCreated="2022-09-17">
        <ClinVarSubmissionID localKey="NM_012452.3:c.204dupA|OMIM:607594" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002573436" DateUpdated="2022-09-17" DateCreated="2022-09-17" Type="SCV" Version="1" SubmitterName="Clinic of Clinical Immunology with Stem Cell Bank, Expert Centre for Rare Diseases - PID, University Hospital &quot;Alexandrovska&quot;" OrgID="508564" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TNFRSF13B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_012452.3:c.204dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607594" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11917960</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7328948" SubmissionDate="2023-04-18" DateLastUpdated="2023-04-30" DateCreated="2023-04-30">
        <ClinVarSubmissionID localKey="3011|OMIM:240500;609529" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV003920575" DateUpdated="2023-04-30" DateCreated="2023-04-30" Type="SCV" Version="1" SubmitterName="Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago" OrgID="506344" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>TNFRSF13B NM_012452.2 exon 3 p.Leu69Thrfs*12 (c.204dupA):This variant has been reported in the literature in at least 5 individuals with Common Variable Immunodeficiency (CVID) or IgA deficiency (IgAD), segregating with disease in at least 4 affected family members. This variant has also been identified in 1 individual with tonsillar hypertrophy (Castigli 2005 PMID:16007086, Castigli 2007 PMID:17392798, Salzer 2009 PMID:18981294, Speletas 2011 PMID:21547394, Freiberger 2012 PMID:22884984, Speletas 2013 PMID:23956760, Pulvirenti 2016 PMID:27123465). This variant is present in 0.5% (58/10358) of Ashkenazi Jewish alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/17-16852292-G-GT?dataset=gnomad_r2_1). Please note, disease causing variants may be present in control databases at low frequencies, reflective of the general population, carrier status, and/or variable expressivity. This variant is present in ClinVar, with several labs classifying this variant as Pathogenic or Likely Pathogenic (Variation ID: 322029). Evolutionary conservation and computational predictive tools for this variant are limited or unavailable. In addition, functional studies have shown a deleterious effect of this variant suggesting no impact to protein expression, activation responses or central B-cell tolerance in naive B cells, but decreased expression on memory B cells with subsequent impaired activation and antibody secretion (Romberg 2015 PMID:26100089). This variant is a duplication of 1 nucleotide at position 204 and creates a premature stop codon 12 amino acids downstream from this location resulting in an absent or abnormal protein. Loss of function variants are a known mechanism of disease for this gene (Romberg 2015 PMID:26100089). In summary, this variant is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TNFRSF13B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh38" Chr="17" alternateAllele="GT" referenceAllele="G" start="16948978" stop="16948978" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="240500" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="609529" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13087641</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7512153" SubmissionDate="2023-07-17" DateLastUpdated="2023-07-22" DateCreated="2023-07-22">
        <ClinVarSubmissionID localKey="53624431|OMIM:240500" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004013327" DateUpdated="2023-07-22" DateCreated="2023-07-22" Type="SCV" Version="1" SubmitterName="Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center" OrgID="1019" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>PVS1, PS3</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TNFRSF13B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_012452.3:c.204dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="240500" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13685737</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7512464" SubmissionDate="2023-07-18" DateLastUpdated="2023-07-22" DateCreated="2023-07-22">
        <ClinVarSubmissionID localKey="17-16852292-G-GT" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004013646" DateUpdated="2023-07-22" DateCreated="2023-07-22" Type="SCV" Version="1" SubmitterName="3billion" OrgID="507830" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16007086</ID>
          </Citation>
          <Comment>The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.040%). The variant is predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000322029 / PMID: 16007086). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>Exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002719" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002090" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0004322" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TNFRSF13B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_012452.3:c.204dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="240500" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13689199</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7699954" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="2192117|TNFRSF13B-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004116505" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The TNFRSF13B c.204dupA variant is predicted to result in a frameshift and premature protein termination (p.Leu69Thrfs*12). This variant has been reported in either the heterozygous or compound heterozygous state in several individuals with either common variable immunodeficiency (CVID) or IgA deficiency (IgAD) (Castigli et al. 2005. PubMed ID: 16007086; Salzer et al. 2009. PubMed ID: 18981294; Speletas et al. 2011. PubMed ID: 21547394; Pulvirenti et al. 2016. PubMed ID: 27123465). At least one patient with this variant developed non-Hodgkin lymphoma as well as CVID (Pulvirenti et al. 2016. PubMed ID: 27123465). This variant is reported in 0.56% of alleles in individuals of Ashkenazi Jewish descent in gnomAD (http://gnomad.broadinstitute.org/variant/17-16852292-G-GT). Frameshift variants in TNFRSF13B are expected to be pathogenic. This variant is interpreted as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TNFRSF13B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_012452.2:c.204dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">TNFRSF13B-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3968524" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="8ea13e7e3765c59bf846dc00072c9a9dadf654ba410823583af51eb5f68ac6db|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002022362" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_012452.3:c.204dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9033421" SubmissionDate="2024-04-17" DateLastUpdated="2024-04-20" DateCreated="2024-04-20">
        <ClinVarSubmissionID localKey="UCSF2311192|OMIM:605258" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004847103" DateUpdated="2024-04-20" DateCreated="2024-04-20" Type="SCV" Version="1" SubmitterName="Genomic Medicine Lab, University of California San Francisco" OrgID="506696" OrganizationCategory="laboratory" OrgAbbreviation="UCSF GML" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TNFRSF13B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_012452.3:c.204dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605258" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14385124</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2471726" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2020-05-12">
        <ClinVarSubmissionID localKey="101520|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001250127" DateUpdated="2024-07-15" DateCreated="2020-05-12" Type="SCV" Version="23" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-12-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TNFRSF13B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="17" alternateAllele="GT" referenceAllele="G" start="16852292" stop="16852292" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2021-07</SubmissionName>
          <SubmissionName>2021-10</SubmissionName>
          <SubmissionName>2022-01</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1204226" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7328948" TraitType="Disease" MappingType="XRef" MappingValue="240500" MappingRef="OMIM">
        <MedGen CUI="C3150354" Name="Immunodeficiency, common variable, 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2471726" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5031043" TraitType="Disease" MappingType="XRef" MappingValue="607594" MappingRef="OMIM">
        <MedGen CUI="C3149378" Name="Immunodeficiency, common variable, 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7512464" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002719" MappingRef="HP">
        <MedGen CUI="C0239998" Name="Recurrent infections" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7328948" TraitType="Disease" MappingType="XRef" MappingValue="609529" MappingRef="OMIM">
        <MedGen CUI="C1836032" Name="Immunoglobulin A deficiency 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="25810" TraitType="Disease" MappingType="Name" MappingValue="IMMUNODEFICIENCY, COMMON VARIABLE, 2" MappingRef="Preferred">
        <MedGen CUI="C3150354" Name="Immunodeficiency, common variable, 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2246111" TraitType="Disease" MappingType="XRef" MappingValue="240500" MappingRef="OMIM">
        <MedGen CUI="C3150354" Name="Immunodeficiency, common variable, 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9033421" TraitType="Disease" MappingType="XRef" MappingValue="605258" MappingRef="OMIM">
        <MedGen CUI="C1720956" Name="Hyper-IgM syndrome type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="25811" TraitType="Disease" MappingType="Name" MappingValue="IMMUNOGLOBULIN A DEFICIENCY 2" MappingRef="Alternate">
        <MedGen CUI="C1836032" Name="Immunoglobulin A deficiency 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7512153" TraitType="Disease" MappingType="XRef" MappingValue="240500" MappingRef="OMIM">
        <MedGen CUI="C3150354" Name="Immunodeficiency, common variable, 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3968524" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1242393" TraitType="Disease" MappingType="XRef" MappingValue="C3150354" MappingRef="MedGen">
        <MedGen CUI="C3150354" Name="Immunodeficiency, common variable, 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7512464" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002090" MappingRef="HP">
        <MedGen CUI="C0032285" Name="Pneumonia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="714442" TraitType="Disease" MappingType="Name" MappingValue="Common Variable Immune Deficiency, Dominant" MappingRef="Preferred">
        <MedGen CUI="CN239265" Name="Common Variable Immune Deficiency, Dominant" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7699954" TraitType="Disease" MappingType="Name" MappingValue="TNFRSF13B-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="TNFRSF13B-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7512464" TraitType="Disease" MappingType="XRef" MappingValue="240500" MappingRef="OMIM">
        <MedGen CUI="C3150354" Name="Immunodeficiency, common variable, 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7512464" TraitType="Finding" MappingType="XRef" MappingValue="HP:0004322" MappingRef="HP">
        <MedGen CUI="C0349588" Name="Short stature" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2021-05-28">SCV001525428</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

